China Merchants Securities
VC Fund
Shenzhen, China
China Merchants Securities is a VC fund in Shenzhen focused on Manufacturing and Biotechnology. China Merchants Securities co. Ltd. provides investors with all-round professional services of securities investment and financing, including securities trading, securities financing and loan, securities issuance and underwriting, merger & acquisition, asset restructuring, financial consultation, asset management, and investment consultation.It wholly owns China Merchants Securities International, China Merchants Futures, and China Merchants Capital Investment, and is a shareholder in BOSERA Funds and China Merchants Fund, building a comprehensive securities service platform integrating both domestic and international business.
- Total investments:
- 50
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries China Merchants Securities invests in
Stages China Merchants Securities invests in
Countries China Merchants Securities invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
|
Qu Long
|
|||
3 more contacts available
Investment Focus
Industry
- Manufacturing 12 (24%)
- Biotechnology 11 (22%)
- Medical 6 (12%)
- Hardware 6 (12%)
- Software 6 (12%)
Stage
- Series B 18 (36%)
- Post-IPO Equity 14 (28%)
- Series A 5 (10%)
- Series C 5 (10%)
- Series D 2 (4%)
Country
- China 42 (84%)
- United States 3 (6%)
- Hong Kong 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Wang Yan
CEO
|
CEO | Total investments: 0 | Find email | |
|
Qu Long
Head of the investment medical
|
Head of the investment medical | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Aixin Semiconductor Technology specializes in the research and development, manufacturing, and sales of semiconductor front-end measurement and testing equipment. It has a production plant of more than 1,000 square meters in Shenzhen, including a thousand-level assembly and commissioning clean room, and a hundred-level, and ten-level laboratoryclean room. | Series B / Jul 20, 2026 | |
|
|
Aixin Semiconductor Technology specializes in the research and development, manufacturing, and sales of semiconductor front-end measurement and testing equipment. It has a production plant of more than 1,000 square meters in Shenzhen, including a thousand-level assembly and commissioning clean room, and a hundred-level, and ten-level laboratoryclean room. | Series B / Jan 25, 2024 | |
|
|
Wei Gao Jie Kang Biological Material specializes in dental medical device research and development, manufacture, sales, and training. Dental implant systems (WEGO/JERICOM/Xteady), oral biomaterials, digital dental diagnosis and treatment equipment, implant surgery tool goods, oral personalized and digital restoration products, and dentalclinical consumable products are the primary items. | Series A / Aug 24, 2023 | |
|
|
Boruspan is a machine tool manufacturing enterprise, engaged in the R&D and manufacturing of high-precision CNC machine tools. | $36.3M / Series D / Apr 24, 2023 | |
|
|
Angkun Vision is an optical inspection service provider. | Venture - Series Unknown / Jan 11, 2023 | |
|
Vital Thin Film Materials
|
Pioneer Thin Film Materials Co., Ltd. is a subsidiary of Pioneer Group, dedicated to R&D, production, sales and recycling of sputtering targets and evaporation materials for vacuum coating. The product series includes targets, ingots, granules and powders made of high-purity metals, alloys, precious metals and ceramic materials, which arewidely used in display, photovoltaic, semiconductor, precision optics, data storage and glass and other fields. | $625M / Series B / Sep 28, 2022 | |
|
|
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services. | $80M / Series B / Aug 21, 2022 | |
|
|
Proton Bio is mainly engaged in gene and cell therapy CDMO service provider, focusing on the field of gene and cell therapy. | $76.3M / Series B / Aug 19, 2022 | |
|
|
Aoquan is a biopharmaceutical company that provides research and development, production, and industrialization of innovative drugs. | $14.8M / Series B / Aug 05, 2022 | |
|
|
SpeedBot is positioned as: the most powerful visual brain for 3D visual perception and robot flexible control in complex scenes for logistics, intelligent manufacturing, new retail, big health, etc.; providing low cost and high efficiency for robot complex interactive scenes 3D visual algorithm, end-of-line software and hardware integration,general vision computing platform services. | $47.2M / Series B / Mar 18, 2022 | |
| See all 50 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does China Merchants Securities invest in?
China Merchants Securities invests primarily in Manufacturing, Biotechnology and Medical startups, most often at Series B and Post-IPO Equity stage. Most of the 50 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact China Merchants Securities?
Public channels for China Merchants Securities include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at China Merchants Securities?
The team at China Merchants Securities includes Wang Yan (CEO) and Qu Long (Head of the investment medical). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!